Logo image of CSTM

CONSTELLIUM SE (CSTM) Stock Fundamental Analysis

NYSE:CSTM - New York Stock Exchange, Inc. - FR0013467479 - Common Stock - Currency: USD

12.14  -0.15 (-1.22%)

After market: 12.1395 0 (0%)

Fundamental Rating

5

Overall CSTM gets a fundamental rating of 5 out of 10. We evaluated CSTM against 153 industry peers in the Metals & Mining industry. There are concerns on the financial health of CSTM while its profitability can be described as average. CSTM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CSTM had positive earnings in the past year.
CSTM had a positive operating cash flow in the past year.
CSTM had positive earnings in 4 of the past 5 years.
In the past 5 years CSTM always reported a positive cash flow from operatings.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

CSTM's Return On Assets of 3.41% is fine compared to the rest of the industry. CSTM outperforms 71.24% of its industry peers.
Looking at the Return On Equity, with a value of 23.63%, CSTM belongs to the top of the industry, outperforming 93.46% of the companies in the same industry.
CSTM has a better Return On Invested Capital (12.50%) than 91.50% of its industry peers.
CSTM had an Average Return On Invested Capital over the past 3 years of 8.33%. This is in line with the industry average of 8.62%.
The 3 year average ROIC (8.33%) for CSTM is below the current ROIC(12.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.41%
ROE 23.63%
ROIC 12.5%
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

CSTM has a better Profit Margin (1.33%) than 64.71% of its industry peers.
CSTM's Profit Margin has declined in the last couple of years.
CSTM has a Operating Margin of 4.03%. This is comparable to the rest of the industry: CSTM outperforms 54.90% of its industry peers.
In the last couple of years the Operating Margin of CSTM has declined.
Looking at the Gross Margin, with a value of 11.88%, CSTM is in line with its industry, outperforming 45.10% of the companies in the same industry.
CSTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.03%
PM (TTM) 1.33%
GM 11.88%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

3

2. Health

2.1 Basic Checks

CSTM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CSTM has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CSTM has been increased compared to 5 years ago.
CSTM has a worse debt/assets ratio than last year.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 3.29 indicates that CSTM is not in any danger for bankruptcy at the moment.
CSTM has a better Altman-Z score (3.29) than 63.40% of its industry peers.
A Debt/Equity ratio of 2.56 is on the high side and indicates that CSTM has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.56, CSTM is doing worse than 91.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF N/A
Altman-Z 3.29
ROIC/WACC1.44
WACC8.68%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.24 indicates that CSTM should not have too much problems paying its short term obligations.
CSTM has a worse Current ratio (1.24) than 78.43% of its industry peers.
CSTM has a Quick Ratio of 1.24. This is a bad value and indicates that CSTM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CSTM (0.53) is worse than 89.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.53
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The earnings per share for CSTM have decreased strongly by -33.17% in the last year.
The Earnings Per Share has been growing slightly by 3.27% on average over the past years.
Looking at the last year, CSTM shows a very strong growth in Revenue. The Revenue has grown by 81.94%.
Measured over the past years, CSTM shows a small growth in Revenue. The Revenue has been growing by 4.43% on average per year.
EPS 1Y (TTM)-33.17%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%124.55%
Revenue 1Y (TTM)81.94%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%8.63%

3.2 Future

Based on estimates for the next years, CSTM will show a very strong growth in Earnings Per Share. The EPS will grow by 103.58% on average per year.
CSTM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.11% yearly.
EPS Next Y178.78%
EPS Next 2Y103.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.47%
Revenue Next 2Y14.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 22.07, the valuation of CSTM can be described as rather expensive.
Based on the Price/Earnings ratio, CSTM is valued a bit cheaper than 71.24% of the companies in the same industry.
When comparing the Price/Earnings ratio of CSTM to the average of the S&P500 Index (26.25), we can say CSTM is valued inline with the index average.
The Price/Forward Earnings ratio is 7.13, which indicates a rather cheap valuation of CSTM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CSTM indicates a rather cheap valuation: CSTM is cheaper than 84.97% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CSTM to the average of the S&P500 Index (22.15), we can say CSTM is valued rather cheaply.
Industry RankSector Rank
PE 22.07
Fwd PE 7.13
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CSTM indicates a rather cheap valuation: CSTM is cheaper than 92.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.27
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSTM has a very decent profitability rating, which may justify a higher PE ratio.
CSTM's earnings are expected to grow with 103.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.12
PEG (5Y)6.76
EPS Next 2Y103.58%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CSTM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CONSTELLIUM SE

NYSE:CSTM (5/30/2025, 8:04:01 PM)

After market: 12.1395 0 (0%)

12.14

-0.15 (-1.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-21 2025-07-21/bmo
Inst Owners93.48%
Inst Owner Change-2.11%
Ins Owners1.48%
Ins Owner ChangeN/A
Market Cap1.74B
Analysts84
Price Target17.6 (44.98%)
Short Float %1.15%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-337.89%
Min EPS beat(2)-952.86%
Max EPS beat(2)277.07%
EPS beat(4)2
Avg EPS beat(4)-181.55%
Min EPS beat(4)-952.86%
Max EPS beat(4)277.07%
EPS beat(8)2
Avg EPS beat(8)-114.34%
EPS beat(12)3
Avg EPS beat(12)-87.57%
EPS beat(16)6
Avg EPS beat(16)-7.76%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)3.03%
Revenue beat(4)1
Avg Revenue beat(4)-3.76%
Min Revenue beat(4)-9.9%
Max Revenue beat(4)3.03%
Revenue beat(8)2
Avg Revenue beat(8)-2.62%
Revenue beat(12)5
Avg Revenue beat(12)-0.54%
Revenue beat(16)9
Avg Revenue beat(16)1.13%
PT rev (1m)2.99%
PT rev (3m)-2.82%
EPS NQ rev (1m)25.14%
EPS NQ rev (3m)-9.21%
EPS NY rev (1m)14.04%
EPS NY rev (3m)-14.03%
Revenue NQ rev (1m)-3.13%
Revenue NQ rev (3m)-8.67%
Revenue NY rev (1m)1.33%
Revenue NY rev (3m)11.33%
Valuation
Industry RankSector Rank
PE 22.07
Fwd PE 7.13
P/S 0.13
P/FCF N/A
P/OCF 5.83
P/B 2.33
P/tB 2.87
EV/EBITDA 4.27
EPS(TTM)0.55
EY4.53%
EPS(NY)1.7
Fwd EY14.03%
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)2.08
OCFY17.15%
SpS92.34
BVpS5.21
TBVpS4.23
PEG (NY)0.12
PEG (5Y)6.76
Profitability
Industry RankSector Rank
ROA 3.41%
ROE 23.63%
ROCE 15.83%
ROIC 12.5%
ROICexc 12.96%
ROICexgc 13.54%
OM 4.03%
PM (TTM) 1.33%
GM 11.88%
FCFM N/A
ROA(3y)3.45%
ROA(5y)3.08%
ROE(3y)23.43%
ROE(5y)N/A
ROIC(3y)8.33%
ROIC(5y)8.11%
ROICexc(3y)8.79%
ROICexc(5y)8.68%
ROICexgc(3y)9.69%
ROICexgc(5y)9.98%
ROCE(3y)10.54%
ROCE(5y)10.26%
ROICexcg growth 3Y-18.02%
ROICexcg growth 5Y-6.42%
ROICexc growth 3Y-13.61%
ROICexc growth 5Y-3.24%
OM growth 3Y-14.91%
OM growth 5Y-4.66%
PM growth 3Y-43.25%
PM growth 5Y-5.23%
GM growth 3Y6.67%
GM growth 5Y5.15%
F-Score8
Asset Turnover2.55
Health
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF N/A
Debt/EBITDA 2.29
Cap/Depr 134.34%
Cap/Sales 3.07%
Interest Coverage 6.05
Cash Conversion 35.72%
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.53
Altman-Z 3.29
F-Score8
WACC8.68%
ROIC/WACC1.44
Cap/Depr(3y)117.66%
Cap/Depr(5y)102.03%
Cap/Sales(3y)4.56%
Cap/Sales(5y)4.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.17%
EPS 3Y-38.65%
EPS 5Y3.27%
EPS Q2Q%124.55%
EPS Next Y178.78%
EPS Next 2Y103.58%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)81.94%
Revenue growth 3Y6.04%
Revenue growth 5Y4.43%
Sales Q2Q%8.63%
Revenue Next Year16.47%
Revenue Next 2Y14.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.57%
EBIT growth 3Y-9.78%
EBIT growth 5Y-0.44%
EBIT Next Year102.52%
EBIT Next 3Y37.28%
EBIT Next 5YN/A
FCF growth 1Y-191.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-30.16%
OCF growth 3Y-5.53%
OCF growth 5Y-7.6%